Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Affinity and Avidity01:41

Affinity and Avidity

Overview
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting long-standing biological questions through evolving technologies.

Bioscience trends·2026
Same author

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026
Same author

A Modular and Scalable FPGA Platform for Intelligent, High-Throughput Image-Activated Cell Sorting.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Glutathione-activatable bola dendrimers mediate tumor-specific cytosolic siRNA delivery <i>via</i> dynamic thiol-disulfide exchange.

Biomaterials science·2026
Same author

Self-assembling dendrimer nanoparticles in cancer therapy.

Nanomedicine (London, England)·2026
Same author

C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same journal

The Hedgehog Pathway Effector Smoothened Exhibits Signaling Competency in the Absence of Ciliary Accumulation.

Chemistry & biology·2017
Same journal

DIVERSE System: De Novo Creation of Peptide Tags for Non-enzymatic Covalent Labeling by In Vitro Evolution for Protein Imaging Inside Living Cells.

Chemistry & biology·2015
Same journal

Differential Regulation of Specific Sphingolipids in Colon Cancer Cells during Staurosporine-Induced Apoptosis.

Chemistry & biology·2015
Same journal

Synthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase Iα.

Chemistry & biology·2015
Same journal

Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.

Chemistry & biology·2015
Same journal

Vitamin C as Cancer Destroyer, Investigating Sulfhydration, and the Variability in CFTR Interactome.

Chemistry & biology·2015
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Primer-Free Aptamer Selection Using A Random DNA Library
11:14

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

Bivalent aptamers deliver the punch.

Jiehua Zhou1, John J Rossi

  • 1Division of Molecular Biology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

Chemistry & Biology
|July 19, 2008
PubMed
Summary
This summary is machine-generated.

Researchers developed a bivalent aptamer device that acts as a receptor agonist. This novel chemical antibody offers enhanced avidity compared to traditional antibodies for therapeutic uses.

More Related Videos

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

Related Experiment Videos

Last Updated: Jul 3, 2026

Primer-Free Aptamer Selection Using A Random DNA Library
11:14

Primer-Free Aptamer Selection Using A Random DNA Library

Published on: July 26, 2010

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction
03:38

Aptamer-Based Target Detection Facilitated by a 3-Stage G-Quadruplex Isothermal Exponential Amplification Reaction

Published on: October 6, 2022

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
12:23

In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

Published on: September 7, 2022

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Drug Discovery

Background:

  • Aptamers, also known as chemical antibodies, are engineered nucleic acid or peptide molecules that bind to a specific target.
  • Multimerized aptamers have been explored for enhanced therapeutic applications.

Purpose of the Study:

  • To develop a bivalent aptamer-molecular device engineered as a receptor agonist.
  • To compare the functional properties and avidity of the developed aptamer device against a corresponding antibody.

Main Methods:

  • Engineering of a bivalent aptamer-molecular device.
  • Functional characterization of the aptamer device as a receptor agonist.
  • Comparative analysis of avidity with a corresponding antibody.

Main Results:

  • Successful development of a bivalent aptamer-molecular device functioning as a receptor agonist.
  • The aptamer device demonstrated equivalent functional properties to a corresponding antibody.
  • The bivalent aptamer device exhibited significantly stronger avidity than the antibody.

Conclusions:

  • Bivalent aptamer-molecular devices can be engineered as potent receptor agonists.
  • These aptamer-based devices offer superior avidity compared to antibodies, suggesting enhanced therapeutic potential.